Xi’an Deli Biochemical Industry Co., Ltd. Shines at CPHI & PMEC China 2025
June 24–26, 2025, CPHI & PMEC China 2025, Asia’s premier pharmaceutical event, was held at the Shanghai New International Expo Centre (SNIEC). The show hosted over 3,500 exhibitors and more than 90,000 professional visitors, covering APIs, excipients, formulations, machinery, and packaging across the industry.
Technical exchanges on inclusion mechanisms, process optimization, and application cases drew sustained interest from global formulators.
Booth E3Q10: Featured flagship products HPBCD and SBECD, alongside new launches including Glucosamine Sulfate Sodium Chloride, Vonoprazan Fumarate, Menatetrenone, and Icodextrin.
Our technical team engaged visitors in deep discussions on inclusion complexation, process improvements, and real-world application scenarios.
Global Procurement:
Buyers from Europe, North America, Southeast Asia, and Japan & Korea confirmed multiple letters of intent on the spot.
One-on-One Meetings:
Conducted in-depth project discussions on sustained-release systems and specialized dissolution profiles with leading pharmaceutical and medical device firms.
Certifications:
Our ISO 9001, HALAL certifications and DMF registrations underscored our commitment to quality and compliance.
This event showcased Deli Biochemical’s robust R&D and manufacturing capabilities and laid a solid foundation for further international expansion. Upholding our motto of “Quality First, Innovation Driven,” we will deepen technological innovation and strengthen partnerships worldwide to drive the pharmaceutical industry forward.
Photos from our booth E3Q10 are shown below. For more highlights, please follow our official WeChat account or visit our website.
